Novartis AG (NVS)

Hold Recap: Q2 2026

Novartis Returns to Growth, Then Tells You Five Points of It Reverse in the Second Half

Hold Recap: Q1 2026

Novartis Misses in the Exact Shape It Guided, While Net Debt Adds $16 Billion in Ninety Days

Hold Recap: Q4 2025

Novartis Clears the 40% Margin Bar Two Years Early, Then Guides to Its First Core Profit Decline in Five Years